Drawing for VARIANTYX

USPTO serial 99874556

VARIANTYX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
VELTEN, MALLORY KATE
Law office
TMO LAW OFFICE 123

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with VARIANTYX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Liebowitz

Rebecca Liebowitz Venable LLPPO Box 34385Washington, DC 20043-9998United States

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of genetic disorders, cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Genetic testing apparatus for medical purposes; Diagnostic kits comprising of test tubes, collection containers and tools, for collecting biological samples for use in medical testingACTIVE—
042Scientific laboratory services in the field of genomics; Research laboratory analysis services in the field of genetic sequencing, analysis and diagnosis of biological tumor sample; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms for providing a diagnostic report based on genetic tumor profile; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing healthcare professionals information about a patient's diagnosis, prognosis and treatment recommendations; Research and development of pharmaceuticals for the treatment of hereditary diseases and cancerACTIVE—
044Genetic testing for medical purposes; Consulting services in the field of diagnosis and treatment of cancer and hereditary disease; Consulting services in the field of genetic testing for medical purposes; Genetic counseling; Medical testing for diagnostic or treatment purposes in the field of DNA, RNA, genetics, genetic testing and genetic sequencing in the field of oncology and in the field of hereditary diseases; Providing information about genetic testing for medical purposes; Genetic testing for cancer risk for medical purposes; Providing medical information in the field of genetic tumor profiles via the preparation of medical reports, namely, diagnostic reports; Providing medical information of genetic variants to assist with treatment or care management by healthcare professionals (HCP) via medical reports, namely, clinical reports; providing information relating to the treatment and prognosis of cancer and hereditary diseases; Providing medical information to healthcare professionals in the form of reports in the fields of genetic diseases and cancer diagnostics, treatment and prognosis; Providing medical information via a website; Providing medical information in the field of patient genetic data for diagnosis and treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory analysis services relating to the treatment of persons; Medical diagnosis and treatment of patients, namely, analysis of biological tumor sample and genetic sequencing; Medical pathology services; Medical diagnosis and treatment of persons, namely, analysis of biological tumor sample for medical purposes; Medical testing for diagnostic or treatment purposes in the field of laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2026DOCKASSIGNED TO EXAMINER—
Oct 20, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 9, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance